Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the PK, safety and tolerability of Cenicriviroc (CVC) administered with and
without Dolutegravir (DTG) and CVC with and without a single dose of Midazolam in healthy
subjects.